Absolute values of <i>M</i>₁ and <i>M</i>₂. by Tobit Führes (12647099)

“…Seven healthy volunteers underwent diffusion-weighted magnetic resonance imaging (DWI) with five diffusion encoding schemes (monopolar, velocity-compensated (<i>M</i>₁ = 0), acceleration-compensated (<i>M</i>₁ = <i>M</i>₂ = 0), 84%-<i>M</i>₁–<i>M</i>₂-compensated, 67%-<i>M</i>₁–<i>M</i>₂-compensated) at b-values of 50 and 800 s/mm² at a constant echo time of 70 ms. …”

Liver azoxystrobin residues after 1 and 2 months treatment with different doses of azoxystrobin on male rats. by Ekramy Halawa (11785086)

Death probability (%) of newly developed branches of persimmons according to the densities of <i>P</i>. <i>shantungensis</i> egg masses. by Sunghoon Baek (7042535)

Data Sheet 7_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 6_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 1_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 3_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 8_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 4_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 5_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 2_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Clinical and Parasitological Features of Patients with American Cutaneous Leishmaniasis that Did Not Respond to Treatment with Meglumine Antimoniate by Jairo E. Perez-Franco (3166050)

“…<i>braziliensis</i> (95.4%) and 35% of the parasites isolated showed a significant decrease in <i>in vitro</i> Glucanatime susceptibility associated with previous administration of the medicament. …”

Effects of busulfan treatment on CX43 and N-Cadherin. by Lingjun Zhao (21763122)

“…<p>The gap junction protein CX43 (A) and the ectoplasmic specialization-related protein N-Cadherin (B) were detected by immunofluorescence assay. …”

Comparing encoding efficiency of odorants’ correlation. by Mario Pannunzi (553941)

Encoding concentration ratio with average PN activity. by Mario Pannunzi (553941)

Responses to synchronous pulses of the control, LN, mix and NSI model. by Mario Pannunzi (553941)

Comparing encoding efficiency of odorants’ correlation, similar results of Fig 10 using threshold 150 Hz. by Mario Pannunzi (553941)

Validation of AgRP neuron-specific <i>Girk1</i> and <i>Girk2</i> deletion. by Youjin Oh (3308670)

Cells lacking <i>efgA</i> detoxify intracellular FA during exogenous FA stress. by Zachary T. Hying (21512605)

Spatial relationship between <i>Taenia solium</i> tapeworm carriers and necropsy cyst burden in pigs by Ian W. Pray (2585908)

“…The prevalence of pig infection was greatest within 50 meters of a tapeworm carrier and decreased monotonically as distance increased. …”